NO992005L - New cis-3,4-chromane derivatives that can be used in the prevention or treatment of ° estrogen-related diseases or syndromes - Google Patents
New cis-3,4-chromane derivatives that can be used in the prevention or treatment of ° estrogen-related diseases or syndromesInfo
- Publication number
- NO992005L NO992005L NO992005A NO992005A NO992005L NO 992005 L NO992005 L NO 992005L NO 992005 A NO992005 A NO 992005A NO 992005 A NO992005 A NO 992005A NO 992005 L NO992005 L NO 992005L
- Authority
- NO
- Norway
- Prior art keywords
- syndromes
- estrogen
- prevention
- treatment
- related diseases
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Foreliggende oppfinnelse ved- rører terapeutisk aktive forbindelser med formel (I) (D en fremgangsmåte for fremstilling av disse forbindelsene, og farmasøytiske preparater som omfatter forbindelsene. De nye forbindelsene kan anvendes ved forhindring eller behandling av østro- genrelaterte sykdommer eller syndromer.BACKGROUND OF THE INVENTION The present invention relates to therapeutically active compounds of formula (I) (D) a process for the preparation of these compounds, and to pharmaceutical compositions comprising the compounds.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK119996 | 1996-10-28 | ||
PCT/DK1997/000485 WO1998018778A1 (en) | 1996-10-28 | 1997-10-28 | Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
Publications (2)
Publication Number | Publication Date |
---|---|
NO992005D0 NO992005D0 (en) | 1999-04-27 |
NO992005L true NO992005L (en) | 1999-06-25 |
Family
ID=8102089
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO992005A NO992005L (en) | 1996-10-28 | 1999-04-27 | New cis-3,4-chromane derivatives that can be used in the prevention or treatment of ° estrogen-related diseases or syndromes |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0934299A1 (en) |
JP (1) | JP2001502710A (en) |
AU (1) | AU4772297A (en) |
CA (1) | CA2270056A1 (en) |
IL (1) | IL129618A0 (en) |
NO (1) | NO992005L (en) |
WO (1) | WO1998018778A1 (en) |
ZA (1) | ZA979649B (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0944613B1 (en) * | 1996-12-13 | 2002-10-09 | Chugai Seiyaku Kabushiki Kaisha | Benzopyran derivatives |
JP2000119187A (en) * | 1998-10-15 | 2000-04-25 | Taisho Pharmaceut Co Ltd | Composition for preventing or improving depressive feeling |
ATE532777T1 (en) | 2004-09-21 | 2011-11-15 | Marshall Edwards Inc | SUBSTITUTED CHROMEDER DERIVATIVES, MEDICATIONS AND APPLICATIONS IN THERAPY |
US8080675B2 (en) | 2004-09-21 | 2011-12-20 | Marshall Edwards, Inc. | Chroman derivatives, medicaments and use in therapy |
EP2635121B1 (en) | 2010-11-01 | 2020-01-08 | MEI Pharma, Inc. | Isoflavonoid compounds and methods for the treatment of cancer |
PL3253208T3 (en) | 2015-02-02 | 2021-11-08 | Mei Pharma, Inc. | Combination therapies for use in the treatment of breast cancer |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3340276A (en) * | 1964-04-01 | 1967-09-05 | Ciba Geigy Corp | 3, 4-diphenyl-chromans |
DE1543749A1 (en) * | 1966-02-16 | 1969-12-11 | Merck Ag E | Process for the preparation of 3,4-cis-4-aryl-isoflavans |
US5280040A (en) * | 1993-03-11 | 1994-01-18 | Zymogenetics, Inc. | Methods for reducing bone loss using centchroman derivatives |
HUP9702244A3 (en) * | 1995-01-13 | 1999-12-28 | Novo Nordisk As | Use of 3,4-diphenyl chromans for manufacture of a pharmaceutical composition for treatment or prophylaxis of gynaecological disorders |
-
1997
- 1997-10-28 AU AU47722/97A patent/AU4772297A/en not_active Abandoned
- 1997-10-28 JP JP10519944A patent/JP2001502710A/en active Pending
- 1997-10-28 EP EP97910266A patent/EP0934299A1/en not_active Withdrawn
- 1997-10-28 CA CA002270056A patent/CA2270056A1/en not_active Abandoned
- 1997-10-28 ZA ZA9709649A patent/ZA979649B/en unknown
- 1997-10-28 WO PCT/DK1997/000485 patent/WO1998018778A1/en not_active Application Discontinuation
- 1997-10-28 IL IL12961897A patent/IL129618A0/en unknown
-
1999
- 1999-04-27 NO NO992005A patent/NO992005L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2270056A1 (en) | 1998-05-07 |
ZA979649B (en) | 1998-04-28 |
NO992005D0 (en) | 1999-04-27 |
JP2001502710A (en) | 2001-02-27 |
EP0934299A1 (en) | 1999-08-11 |
IL129618A0 (en) | 2000-02-29 |
AU4772297A (en) | 1998-05-22 |
WO1998018778A1 (en) | 1998-05-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EG20001A (en) | Process for preparing of novel hydrox-amic acid and N-hydroxyurea derivatives and their use | |
AU563748B2 (en) | Quinolone carboxylic acids | |
NO20025601L (en) | Arylmethylamine derivatives for use as tryptase inhibitors | |
MD1838F2 (en) | 5,6-dichlorbenzimidazole derivatives, process for obtaining thereof, pharmaceutical composition and method of treatment or prevention of herpetic viral infections | |
ATE233250T1 (en) | SACCHARINE DERIVATIVES AS PROTEOLYTIC ENZYMIN HIBITORS | |
NO971625L (en) | Novel peptides with immunomodulatory effects | |
RU95111308A (en) | Derivatives of 2-amino-4-phenyl-4-oxobutyric acid, methods of synthesis, pharmaceutical composition | |
NO992003L (en) | New cis-3,4-chromane derivatives that can be used in the prevention or treatment of ° estrogen-related diseases or syndromes | |
DE69927584D1 (en) | PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF STOMACH DISEASES | |
NO992010L (en) | New cis-3,4-chromane derivatives that can be used in the prevention or treatment of ° estrogen-related diseases or syndromes | |
NO992008L (en) | New (+) enantiomers of cis-3,4-chromane derivatives that can be used in the prevention or treatment of ° estrogen-related diseases or syndromes | |
NO992005L (en) | New cis-3,4-chromane derivatives that can be used in the prevention or treatment of ° estrogen-related diseases or syndromes | |
NO992009L (en) | New trans-3,4-chromane derivatives that can be used in the prevention or treatment of ° estrogen-related diseases or syndromes | |
NO992006D0 (en) | New cis-3,4-chromane derivatives that can be used in the prevention or treatment of ° estrogen-related diseases or syndromes | |
NO992002L (en) | New cis-3,4-chromane derivatives that can be used in the prevention or treatment of ° estrogen-related diseases or syndromes | |
NO992007L (en) | Novel (-) Enantiomers of cis-3,4-chromane derivatives that can be used in the prevention or treatment of ° estrogen-related diseases or syndromes | |
NO992004L (en) | New cis-3,4-chromane derivatives that can be used in the prevention or treatment of ° estrogen-related diseases or syndromes | |
FI932654A0 (en) | Hydroxamsyraderivat, som hindrar lipoxigenas | |
EP0386920A3 (en) | 2-hydroxy-3-thienyloxypropylamino derivatives | |
HK1009334A1 (en) | New 17(3-imino-2-alkyl-propenyl)-5beta 14beta-androstane derivatives active on the cardiovascular system processes for their preparation and pharmaceutical compositions containing same | |
WO1998057910A3 (en) | Cyclooxygenase-i selective inhibitors and the use thereof as analgesic, antiinflammatory and antiarthritic agents | |
RU93030824A (en) | Drug for the treatment of psoriasis "Dermapichtol" |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |